← FDA DRUG APPROVALS

FDA ANDA · ANDA074559

NITROGLYCERIN

Sponsor: MYLAN TECHNOLOGIES

APPLICATION
ANDA074559
TYPE
ANDA
ORIGINAL APPROVAL
1996-08-30
LATEST ACTION
2002-07-15
ROUTE
TRANSDERMAL
DOSAGE FORM
FILM, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

NITROGLYCERINPrescription
NITROGLYCERIN 0.2MG/HR · FILM, EXTENDED RELEASE · TRANSDERMAL
NITROGLYCERINPrescription
NITROGLYCERIN 0.6MG/HR · FILM, EXTENDED RELEASE · TRANSDERMAL
NITROGLYCERINPrescription
NITROGLYCERIN 0.1MG/HR · FILM, EXTENDED RELEASE · TRANSDERMAL
NITROGLYCERINPrescription
NITROGLYCERIN 0.4MG/HR · FILM, EXTENDED RELEASE · TRANSDERMAL

Approval history

2002-07-15Manufacturing (CMC) · Supplement 5AP
2001-03-19Manufacturing (CMC) · Supplement 4AP
1999-10-27Labeling · Supplement 3AP
1998-12-22Labeling · Supplement 2AP
1997-07-30Manufacturing (CMC) · Supplement 1AP
1996-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →